ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 204 out of 680

$713K Total Retail Price of All Prescriptions

Rank: 154 out of 680

459 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

42% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 5,299 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 810 311 S3 1 4
AMLODIPINE BESYLATE 327 221 2 1
FUROSEMIDE 326 208 3 6
LISINOPRIL 311 137 4 5
MELOXICAM 252 118 5 24
ZOLPIDEM TARTRATE 238 77 6 17
METFORMIN HCL 229 114 7 8
CARVEDILOL 199 89 8 23
NEXIUM 195 51 9 16
AZITHROMYCIN 180 88 10 42
TRAMADOL HCL 157 62 11 18
OMEPRAZOLE 151 94 12 7
LEVOTHYROXINE SODIUM 150 77 13 2
BYSTOLIC 147 99 14 79
SIMVASTATIN 147 94 14 3
CEPHALEXIN 134 48 16 149
GLIMEPIRIDE 129 70 17 29
PRAVASTATIN SODIUM 125 60 18 10
CRESTOR 119 58 19 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 42 20 37
METOPROLOL TARTRATE 114 57 21 12
EXFORGE 106 78 22 151
CLOPIDOGREL 101 54 23 26
KLOR-CON M20 96 80 24 61
WARFARIN SODIUM 93 52 25 20
ATORVASTATIN CALCIUM 89 51 26 11
POTASSIUM CHLORIDE 87 47 27 14
CYCLOBENZAPRINE HCL 87 12 R 27 81
METOPROLOL SUCCINATE 86 34 29 13
LYRICA 85 35 30 77
CLONIDINE HCL 83 50 31 36
LEVOFLOXACIN 83 36 31 97
PLAVIX 77 48 33 39
LOSARTAN-HYDROCHLOROTHIAZIDE 75 43 34 51
DIOVAN HCT 72 32 35 55
TRAZODONE HCL 70 11 36 48
TAMSULOSIN HCL 68 42 37 34
ATENOLOL 68 31 37 19
LANTUS SOLOSTAR 65 42 39 84
CYMBALTA 64 32 40 46
CITALOPRAM HBR 63 13 41 22
FLUCONAZOLE 61 0 42 139
PEN NEEDLE 61 30 42 122
MUPIROCIN 60 32 44 130
CLOTRIMAZOLE-BETAMETHASONE 59 22 45 138
VESICARE 58 39 46 176
DIOVAN 58 36 46 31
LOVASTATIN 56 43 48 44
GABAPENTIN 54 20 49 15
CELEBREX 53 27 50 90
HYDROCHLOROTHIAZIDE 52 33 51 9
CIPROFLOXACIN HCL 51 21 52 57
SERTRALINE HCL 51 25 52 28
CYPROHEPTADINE HCL 50 32 R 54 297
BUSPIRONE HCL 50 13 54 144
PROMETHAZINE HCL 50 20 R 54 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.